Our CEO Einar Pontén is preparing for BioStock Life Science Summit on 17 November at 12:30. He will present our unique approach to treat chronic inflammations and the progress with the lead candidate SOL-116.

It has now been produced in 200L scale and is ready for toxicological studies that will start in December. In parallel we continue to explore more indications and are building a platform of opportunities, while moving forward towards clinical trials in 2022. The summit will be available online, just register at the Biostock website: https://www.summit.biostock.se/